According to ProQR's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 22.2229. At the end of 2023 the company had a P/S ratio of 22.6.
Year | P/S ratio | Change |
---|---|---|
2023 | 22.6 | -66.5% |
2022 | 67.5 | -82.02% |
2021 | 376 | |
2020 | N/A | |
2019 | N/A | |
2018 | N/A | |
2017 | N/A | |
2016 | N/A | |
2015 | N/A | |
2014 | N/A |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Atara Biotherapeutics ATRA | 9.61 | -56.77% | ๐บ๐ธ USA |
Agenus
AGEN | 1.62 | -92.69% | ๐บ๐ธ USA |
Actinium Pharmaceuticals ATNM | > 1000 | 12,640.28% | ๐บ๐ธ USA |